Sex
|
Malignancy
|
Observed Events Bonn cohort 1996 - 2008
|
Expected Events*
|
SIR (95% CI)
|
p-Value
|
---|
| |
n
|
n
| | |
Male
|
Kaposi
|
41
|
< 0.1
|
5682.6 (4076.3 - 7555.2)
|
< 0.001
|
|
NHL
|
28
|
0.8
|
35.0 (23.3 - 49.2)
|
< 0.001
|
|
Hodgkin
|
8
|
0.2
|
38.7 (16.5 - 70.2)
|
< 0.001
|
|
Liver
|
7
|
0.4
|
18.2 (7.2 - 34.1)
|
< 0.001
|
|
Anal
|
6
|
0.1
|
87.8 (31.6 - 172.1)
|
< 0.001
|
|
Lung
|
5
|
3.3
|
1.5 (0.5 - 3.1)
|
0.509
|
|
Oropharyngeal
|
3
|
2.4
|
1.1 (0.2 - 2.7)
|
0.905
|
|
Colorectal
|
3
|
2.7
|
1.1 (0.2 - 2.8)
|
0.920
|
|
CUP
|
2
|
0.6
|
3.5 (0.3 - 10.1)
|
0.215
|
|
Melanoma
|
1
|
2.1
|
0.5 (0.0 - 1.9)
|
0.682
|
|
Thyroid
|
1
|
0.2
|
5.2 (0.0 - 20.6)
|
0.478
|
|
Renal
|
1
|
0.9
|
1.1 (0.0 - 4.3)
|
0.660
|
|
All cancer
|
106
|
24.1
|
4.4 (3.6 - 5.3)
|
< 0.001
|
|
Infection-related
|
89
|
1.2
|
75.5 (60.6 - 92.0)
|
< 0.001
|
|
Non-Infect. related
|
17
|
21.6
|
0.8 (0.5 - 1.2)
|
0.374
|
Female
|
Cervix
|
6
|
1.5
|
4.0 (1.5 - 7.9)
|
0.001
|
|
Kaposi
|
2
|
< 0.1
|
277.2 (26.1 - 794.5)
|
< 0.001
|
|
NHL
|
2
|
0.1
|
18.2 (1.7 - 52.1)
|
< 0.001
|
|
Anal
|
2
|
< 0.1
|
115.2 (10.9 - 330.1)
|
< 0.001
|
|
Breast
|
1
|
1.5
|
0.7 (0.0 - 2.6)
|
1.000
|
|
Endometrium
|
1
|
0.2
|
5.3 (0.0 - 20.9)
|
0.472
|
|
Thyroid
|
1
|
0.1
|
8.0 (0.0 - 31.4)
|
0.289
|
|
All cancer
|
15
|
6.0
|
2.5 (1.4 - 3.9)
|
< 0.001
|
|
Infection-related
|
12
|
1.6
|
7.3 (3.8 - 12.0)
|
< 0.001
|
|
Non-Infect. Related
|
3
|
4.1
|
0.7 (0.1 - 1.8)
|
0.780
|
- * Expected events within the Bonn cohort based on the age-specific rates of the Saarland population (11).